Your browser doesn't support javascript.
loading
Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.
Noor, Nudrat; Ebekozien, Osagie; Levin, Laura; Stone, Sheri; Sparling, David P; Rapaport, Robert; Maahs, David M.
Affiliation
  • Noor N; Quality Improvement and Population Health, T1D Exchange, Boston, MA nnoor@t1dexchange.org.
  • Ebekozien O; Quality Improvement and Population Health, T1D Exchange, Boston, MA.
  • Levin L; University of Mississippi Medical Center, Jackson, MS.
  • Stone S; Lurie Children Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Sparling DP; State University of New York Upstate Medical University, Syracuse, NY.
  • Rapaport R; Harold Hamm Diabetes Center, University of Oklahoma College of Medicine, Oklahoma City, OK.
  • Maahs DM; Icahn School of Medicine at Mount Sinai, New York, NY.
Diabetes Care ; 44(8): e160-e162, 2021 08.
Article in En | MEDLINE | ID: mdl-34385347

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Diabetes Care Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Diabetes Care Year: 2021 Document type: Article Country of publication: United States